$0.763600
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
AlloVir (NASDAQ:ALVR) Stock Quotes, Forecast and News Summary
AlloVir Stock (NASDAQ: ALVR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy AlloVir (ALVR) stock?
You can purchase shares of AlloVir (NASDAQ:ALVR) through any online brokerage.
Who are AlloVir (ALVR) competitors?
Other companies in AlloVir’s space includes: CytomX Therapeutics (NASDAQ:CTMX), bluebird bio (NASDAQ:BLUE), Immuneering (NASDAQ:IMRX), Armata Pharmaceuticals (AMEX:ARMP) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the forecast, or price target, for AlloVir (ALVR) stock?
AlloVir has a consensus price target of $12.64.
What is the current price for AlloVir (ALVR)?
The stock price for AlloVir (NASDAQ: ALVR) is $0.7636 last updated September 24, 2024 at 4:00 PM EDT.
Does AlloVir (ALVR) pay a dividend?
There are no upcoming dividends for AlloVir.
When is AlloVir (NASDAQ:ALVR) reporting earnings?
AlloVir’s Q3 earnings are confirmed for Thursday, October 31, 2024.
Is AlloVir (ALVR) going to split?
There is no upcoming split for AlloVir.
What sector and industry does AlloVir (ALVR) operate in?
AlloVir is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.